Literature DB >> 15564486

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees.

Catherine B Bigger1, Bernadette Guerra, Kathleen M Brasky, Gene Hubbard, Michael R Beard, Bruce A Luxon, Stanley M Lemon, Robert E Lanford.   

Abstract

Hepatitis C virus (HCV) infections represent a global health problem and are a major contributor to end-stage liver disease including cirrhosis and hepatocellular carcinoma. An improved understanding of the parameters involved in disease progression is needed to develop better therapies and diagnostic markers of disease manifestation. To better understand the dynamics of host gene expression resulting from persistent virus infection, DNA microarray analyses were conducted on livers from 10 chimpanzees persistently infected with HCV. A total of 162 genes were differentially regulated in chronically infected animals compared to uninfected controls. Many genes exhibited a remarkable consistency in changes in expression in the 10 chronically infected animals. A second method of analysis identified 971 genes altered in expression during chronic infection at a 99% confidence level. As with acute-resolving HCV infections, many interferon (IFN)-stimulated genes (ISGs) were transcriptionally elevated, suggesting an ongoing response to IFN and/or double-stranded RNA which is amplified in downstream ISG expression. Thus, persistent infection with HCV results in a complex and partially predictable pattern of gene expression, although the underlying mechanisms regulating the different pathways are not well defined. A single genotype 3-infected animal was available for analysis, and this animal exhibited reduced levels of ISG expression compared to levels of expression with genotype 1 infections and increased expression of a number of genes potentially involved in steatosis. Gene expression data in concert with other observations from HCV infections permit speculation on the regulation of specific aspects of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564486      PMCID: PMC533929          DOI: 10.1128/JVI.78.24.13779-13792.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  88 in total

1.  Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline.

Authors:  Xiaonan Zhu; Jiannan Song; Mei-Heng Mar; Lloyd J Edwards; Steven H Zeisel
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease.

Authors:  Eileen Foy; Kui Li; Chunfu Wang; Rhea Sumpter; Masanori Ikeda; Stanley M Lemon; Michael Gale
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

3.  Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C.

Authors:  Xuhuai Ji; Ramsey Cheung; Stewart Cooper; Qingqin Li; Harry B Greenberg; Xiao-Song He
Journal:  Hepatology       Date:  2003-03       Impact factor: 17.425

4.  Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

Authors:  Thierry Poynard; John McHutchison; Michael Manns; Rob P Myers; Janice Albrecht
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

5.  Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection.

Authors:  Gerry C MacQuillan; Cyril Mamotte; William D Reed; Gary P Jeffrey; Jane E Allan
Journal:  J Med Virol       Date:  2003-06       Impact factor: 2.327

6.  Steatosis in chronic hepatitis C: association with increased messenger RNA expression of collagen I, tumor necrosis factor-alpha and cytochrome P450 2E1.

Authors:  Peter A Gochee; Julie R Jonsson; Andrew D Clouston; Nirmala Pandeya; David M Purdie; Elizabeth E Powell
Journal:  J Gastroenterol Hepatol       Date:  2003-04       Impact factor: 4.029

7.  Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.

Authors:  Motohiro Sekiya; Naoya Yahagi; Takashi Matsuzaka; Yuho Najima; Masanori Nakakuki; Ryozo Nagai; Shun Ishibashi; Jun-ichi Osuga; Nobuhiro Yamada; Hitoshi Shimano
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

8.  Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.

Authors:  Maria W Smith; Zhaoxia N Yue; Marcus J Korth; Hao A Do; Loreto Boix; Nelson Fausto; Jordi Bruix; Robert L Carithers; Michael G Katze
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

9.  Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons.

Authors:  Rainer Gosert; Denise Egger; Volker Lohmann; Ralf Bartenschlager; Hubert E Blum; Kurt Bienz; Darius Moradpour
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

10.  Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein.

Authors:  Gary K Geiss; Victoria S Carter; Yupeng He; Bartlomiej K Kwieciszewski; Ted Holzman; Marcus J Korth; Catherine A Lazaro; Nelson Fausto; Roger E Bumgarner; Michael G Katze
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  127 in total

1.  Plasmacytoid dendritic cells as guardians in hepatitis C virus-infected liver.

Authors:  Selena M Sagan; Peter Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

Review 2.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.

Authors:  Ying Huang; Jordan J Feld; Ronda K Sapp; Santosh Nanda; Jiing-Huey Lin; Lawrence M Blatt; Michael W Fried; Krishna Murthy; T Jake Liang
Journal:  Gastroenterology       Date:  2006-11-29       Impact factor: 22.682

Review 4.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

5.  Fatty liver in chronic hepatitis C infection: unravelling the mechanisms.

Authors:  Jude A Oben; Emma Paulon
Journal:  Gut       Date:  2007-09       Impact factor: 23.059

6.  Hepatitis C virus host cell interactions uncovered.

Authors:  Judith M Gottwein; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-07       Impact factor: 11.205

7.  The induction of type I interferon production in hepatitis C-infected patients.

Authors:  Lawrence M Pfeffer; Margaret A Madey; Caroline A Riely; Jaquelyn F Fleckenstein
Journal:  J Interferon Cytokine Res       Date:  2009-05       Impact factor: 2.607

8.  Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.

Authors:  Timothy Sheahan; Naoko Imanaka; Svetlana Marukian; Marcus Dorner; Peng Liu; Alexander Ploss; Charles M Rice
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

9.  Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver.

Authors:  S F Wieland; S Asabe; R E Engle; R H Purcell; F V Chisari
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

10.  Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection.

Authors:  Robert E Lanford; Elisabeth S Hildebrandt-Eriksen; Andreas Petri; Robert Persson; Morten Lindow; Martin E Munk; Sakari Kauppinen; Henrik Ørum
Journal:  Science       Date:  2009-12-03       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.